Depósito Digital de Documentos de la UAB Encontrados 27 registros  1 - 10siguientefinal  ir al registro: La búsqueda tardó 0.00 segundos. 
1.
10 p, 2.3 MB Global and Regional Deep Learning Models for Multiple Sclerosis Stratification From MRI / Coll, Llucia (Hospital Universitari Vall d'Hebron) ; Pareto, Deborah (Hospital Universitari Vall d'Hebron) ; Carbonell-Mirabent, Pere (Hospital Universitari Vall d'Hebron) ; Cobo-Calvo, Álvaro (Hospital Universitari Vall d'Hebron) ; Arrambide, Georgina (Hospital Universitari Vall d'Hebron) ; Vidal-Jordana, Angela (Hospital Universitari Vall d'Hebron) ; Comabella, Manuel (Hospital Universitari Vall d'Hebron) ; Castilló, Joaquin (Hospital Universitari Vall d'Hebron) ; Rodríguez-Acevedo, Breogán (Hospital Universitari Vall d'Hebron) ; Zabalza, Ana (Hospital Universitari Vall d'Hebron) ; Galan, Ingrid (Hospital Universitari Vall d'Hebron) ; Midaglia, Luciana (Hospital Universitari Vall d'Hebron) ; Nos, Carlos (Hospital Universitari Vall d'Hebron) ; Auger, Cristina (Universitat Autònoma de Barcelona. Departament de Medicina) ; Alberich, Manel (Hospital Universitari Vall d'Hebron) ; Río, Jordi (Hospital Universitari Vall d'Hebron) ; Sastre-Garriga, Jaume (Hospital Universitari Vall d'Hebron) ; Oliver, Arnau (Universitat de Girona) ; Montalban, Xavier (Universitat Autònoma de Barcelona. Departament de Medicina) ; Rovira, Alex (Hospital Universitari Vall d'Hebron) ; Tintoré, Mar (Hospital Universitari Vall d'Hebron) ; Lladó, Xavier (Universitat de Girona) ; Tur, Carmen (Universitat Autònoma de Barcelona. Departament de Medicina)
Background: The combination of anatomical MRI and deep learning-based methods such as convolutional neural networks (CNNs) is a promising strategy to build predictive models of multiple sclerosis (MS) prognosis. [...]
2023 - 10.1002/jmri.29046
Journal of Magnetic Resonance Imaging  
2.
7 p, 817.8 KB Hepatitis B reactivation is a rare event among patients with resolved infection undergoing anti-CD20 antibodies in monotherapy without antiviral prophylaxis : results from the HEBEM study / Marzo Escartin, Blanca (Universitat Autònoma de Barcelona. Departament de Medicina) ; Vidal-Jordana, Angela (Hospital Universitari Vall d'Hebron) ; Castilló, Joaquín (Hospital Universitari Vall d'Hebron) ; Robles-Sanchez, Miguel-Angel (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Otero-Romero, Susana (Hospital Universitari Vall d'Hebron) ; Tintoré, Mar (Hospital Universitari Vall d'Hebron) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron) ; Buti, Maria (Universitat Autònoma de Barcelona. Departament de Medicina) ; Riveiro Barciela, Mar (Universitat Autònoma de Barcelona. Departament de Medicina)
INTRODUCTION: Prospective data on the risk of hepatitis B reactivation (HBVr) among patients with resolved HBV infection undergoing anti-CD20 antibodies monotherapy is scarce. We aimed to assess the risk of HBVr in patients with resolved HBV infection treated with rituximab or ocrelizumab in monotherapy for multiple sclerosis (MS) or neuromyelitis optica spectrum disorder (NMOSD) without antiviral prophylaxis. [...]
D. Steinkopff-Verlag, 2023 - 10.1007/s00415-023-11973-y
Journal of Neurology, Vol. 271 (2024) p. 134-140  
3.
8 p, 1.6 MB T1/T2-weighted ratio in multiple sclerosis : A longitudinal study with clinical associations / Boaventura de Oliveira, Mateus (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Sastre-Garriga, Jaume (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Garcia-Vidal, Aran (Hospital Universitari Vall d'Hebron) ; Vidal-Jordana, Angela (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Quartana, Davide (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Carvajal-Junco, René (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Auger, Cristina (Hospital Universitari Vall d'Hebron) ; Alberich, Manel (Hospital Universitari Vall d'Hebron) ; Tintoré, Mar (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Rovira, Alex (Hospital Universitari Vall d'Hebron) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Pareto, Deborah (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
Background: T1w/T2-w ratio has been proposed as a clinically feasible MRI biomarker to assess tissue integrity in multiple sclerosis. However, no data is available in the earliest stages of the disease and longitudinal studies analysing clinical associations are scarce. [...]
2022 - 10.1016/j.nicl.2022.102967
NeuroImage, Vol. 34 (2022) , p. 102967  
4.
16 p, 2.3 MB Consenso de expertos sobre el uso de alemtuzumab en la práctica clínica diaria en España / Meca-Lallana, Jose Eustasio (Hospital Clínico Universitario Virgen de la Arrixaca (El Palmar, Múrcia)) ; Fernández-Prada, M. (Hospital Vital Álvarez-Buylla) ; García Vázquez, E. (Hospital Clínico Universitario Virgen de la Arrixaca (El Palmar, Múrcia)) ; Moreno Guillén, S. (Hospital Universitario Ramón y Cajal (Madrid)) ; Otero-Romero, Susana (Hospital Universitari Vall d'Hebron) ; Rus Hidalgo, M. (Hospital Universitario Virgen Macarena (Sevilla, Andalusia)) ; Villar Guimerans, L. M. (Hospital Universitario Ramón y Cajal (Madrid)) ; Eichau Madueño, S. (Hospital Universitario Virgen Macarena (Sevilla, Andalusia)) ; Fernández Fernández, Ó. (Hospital Regional Universitario de Málaga) ; Izquierdo Ayuso, G. (Hospital Vithas Nisa) ; Alvarez-Cermeño, José C (Hospital Universitario Ramón y Cajal (Madrid)) ; Arnal García, C. (Hospital Universitario Virgen de las Nieves (Granada)) ; Arroyo, Rafael (Grupo Quirónsalud (Madrid, Espanya)) ; Brieva Ruiz, Luis (Hospital Arnau de Vilanova (Lleida, Catalunya)) ; Calles, Carmen (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ; García Merino, A. (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ; González Platas, M. (Hospital Universitario de Canarias (La Laguna)) ; Hernández Pérez, M. Á. (Hospital Universitario Nuestra Señora de Candelaria (Santa Cruz de Tenerife)) ; Moral Torres, E. (Hospital de Sant Joan Despí Moisès Broggi) ; Olascoaga Urtaza, J. (Hospital Universitario Donostia-Instituto de Investigación BIODONOSTIA) ; Oliva-Nacarino, P. (Hospital Universitario Central de Asturias) ; Oreja-Guevara, Celia (Hospital Clínico San Carlos (Madrid)) ; Ortiz Castillo, R. (Sanofi-Genzyme) ; Oterino, A. (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ; Prieto González, J. M. (Hospital Clínico Universitario (Santiago de Compostela, Galícia)) ; Ramió-Torrentà, Lluís (Hospital Universitari de Girona Doctor Josep Trueta) ; Rodríguez-Antigüedad, A. (Hospital Universitario de Cruces (Barakaldo, País Basc)) ; Saiz, A. (Hospital Clínic i Provincial de Barcelona) ; Tintoré, Mar (Hospital Universitari Vall d'Hebron) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron)
Introducción: Alemtuzumab es un fármaco de alta eficacia aprobado por la Agencia Europea de Medicamentos como tratamiento modificador de la enfermedad en pacientes con esclerosis múltiple remitente recurrente. [...]
Introduction: Alemtuzumab is a highly effective drug approved by the European Medicines Agency as a disease-modifying drug for the treatment of relapsing-remitting multiple sclerosis. Objective: A consensus document was drafted on the management of alemtuzumab in routine clinical practice in Spain. [...]

2022 - 10.1016/j.nrl.2019.11.003
Neurología, Vol. 37 Núm. 8 (2022) , p. 615-630
2 documentos
5.
12 p, 4.0 MB Deciphering multiple sclerosis disability with deep learning attention maps on clinical MRI / Coll, Llucia (Hospital Universitari Vall d'Hebron) ; Pareto, Deborah (Hospital Universitari Vall d'Hebron) ; Carbonell-Mirabent, Pere (Hospital Universitari Vall d'Hebron) ; Cobo-Calvo, Álvaro (Hospital Universitari Vall d'Hebron) ; Arrambide, Georgina (Hospital Universitari Vall d'Hebron) ; Vidal-Jordana, Angela (Hospital Universitari Vall d'Hebron) ; Comabella, Manuel (Hospital Universitari Vall d'Hebron) ; Castilló, Joaquín (Hospital Universitari Vall d'Hebron) ; Rodríguez Acevedo, Breogán (Hospital Universitari Vall d'Hebron) ; Zabalza, Ana (Hospital Universitari Vall d'Hebron) ; Galan, Ingrid (Hospital Universitari Vall d'Hebron) ; Midaglia, Luciana (Hospital Universitari Vall d'Hebron) ; Nos, Carlos (Hospital Universitari Vall d'Hebron) ; Salerno, Annalaura (Hospital Universitari Vall d'Hebron) ; Auger, Cristina (Hospital Universitari Vall d'Hebron) ; Alberich, Manel (Hospital Universitari Vall d'Hebron) ; Río, Jordi (Hospital Universitari Vall d'Hebron) ; Sastre-Garriga, Jaume (Hospital Universitari Vall d'Hebron) ; Oliver, Arnau (Universitat de Girona. Institut de recerca en visió per computador i robòtica (VICOROB)) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron) ; Rovira, Alex (Hospital Universitari Vall d'Hebron) ; Tintoré, Mar (Hospital Universitari Vall d'Hebron) ; Lladó, Xavier (Universitat de Girona. Institut de recerca en visió per computador i robòtica (VICOROB)) ; Tur, Carmen (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
The application of convolutional neural networks (CNNs) to MRI data has emerged as a promising approach to achieving unprecedented levels of accuracy when predicting the course of neurological conditions, including multiple sclerosis, by means of extracting image features not detectable through conventional methods. [...]
2023 - 10.1016/j.nicl.2023.103376
NeuroImage, Vol. 38 (march 2023)  
6.
8 p, 871.8 KB Oral contraceptives do not modify the risk of a second attack and disability accrual in a prospective cohort of women with a clinically isolated syndrome and early multiple sclerosis / Otero-Romero, Susana (Hospital Universitari Vall d'Hebron) ; Carbonell-Mirabent, Pere (Hospital Universitari Vall d'Hebron) ; Midaglia, Luciana (Hospital Universitari Vall d'Hebron) ; Zuluaga Rodas, María Isabel (Hospital Universitari Vall d'Hebron) ; Galan, Ingrid (Hospital Universitari Vall d'Hebron) ; Cobo-Calvo, Álvaro (Hospital Universitari Vall d'Hebron) ; Río, Jordi (Hospital Universitari Vall d'Hebron) ; Arrambide, Georgina (Hospital Universitari Vall d'Hebron) ; Vidal-Jordana, Angela (Hospital Universitari Vall d'Hebron) ; Castilló, Joaquín (Hospital Universitari Vall d'Hebron) ; Rodríguez Acevedo, Breogán (Hospital Universitari Vall d'Hebron) ; Comabella, Manuel (Hospital Universitari Vall d'Hebron) ; Rodríguez, Marta (Hospital Universitari Vall d'Hebron) ; Tur, Carmen (Hospital Universitari Vall d'Hebron) ; Auger, Cristina (Hospital Universitari Vall d'Hebron) ; Rovira, Alex (Hospital Universitari Vall d'Hebron) ; Sastre-Garriga, Jaume (Hospital Universitari Vall d'Hebron) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron) ; Tintoré, Mar (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
To evaluate whether oral contraceptive (OC) use is associated with the risk of a second attack and disability accrual in women with a clinically isolated syndrome (CIS) and early multiple sclerosis (MS). [...]
2021 - 10.1177/13524585211053001
Multiple sclerosis, Vol. 28 (november 2021) , p. 950-957  
7.
7 p, 813.8 KB Immunoglobulin G immune response to SARS-CoV-2 vaccination in people living with multiple sclerosis within Multiple Sclerosis Partners Advancing Technology and Health Solutions / Cohen, Jeffrey A. (Mellen Center, Neurologic Institute, Cleveland Clinic) ; Bermel, Robert (Mellen Center, Neurologic Institute, Cleveland Clinic) ; Grossman, Cynthia I. (Biogen, Cambridge) ; Hersh, Carrie (Cleveland Clinic (Las Vegas)) ; Hyland, Megan. (University of Rochester. Department of Neurology) ; Mowry, Ellen M. (Johns Hopkins University. Department of Neurology) ; Naismith, Robert (Washington University in St. Louis. Department of Neurology) ; Naylor, Maria L. (Biogen, Cambridge) ; Nicholas, Jacqueline (OhioHealth Multiple Sclerosis Center) ; Rajbhandar, Rajani (Biogen, Cambridge) ; Singh, Carol M. (Biogen, Cambridge) ; Tintoré, Mar (Hospital Universitari Vall d'Hebron) ; Zabalza, Ana (Hospital Universitari Vall d'Hebron) ; Ziemssen, Tjalf (University Clinic Carl-Gustav Carus. Department of Neurology) ; Williams, James R. (Biogen, Cambridge) ; Montalban, Xavier (Universitat Autònoma de Barcelona. Departament de Medicina)
The impact of multiple sclerosis (MS) disease-modifying therapies (DMTs) on SARS-CoV-2 vaccination response is uncertain. Post-SARS-CoV-2 vaccination blood samples across multiple DMTs were tested for SARS-CoV-2 immunoglobulin G (IgG) response. [...]
2022 - 10.1177/13524585211061343
Multiple sclerosis, Vol. 28 Num. 7 (january 2022) , p. 1131-1137  
8.
10 p, 509.3 KB Association of Early Progression Independent of Relapse Activity With Long-term Disability After a First Demyelinating Event in Multiple Sclerosis / Tur, Carmen (Hospital Universitari Vall d'Hebron) ; Carbonell-Mirabent, Pere (Hospital Universitari Vall d'Hebron) ; Cobo-Calvo, Álvaro (Hospital Universitari Vall d'Hebron) ; Otero-Romero, Susana (Hospital Universitari Vall d'Hebron) ; Arrambide, Georgina (Hospital Universitari Vall d'Hebron) ; Midaglia, Luciana (Hospital Universitari Vall d'Hebron) ; Castilló, Joaquín (Hospital Universitari Vall d'Hebron) ; Vidal-Jordana, Angela (Hospital Universitari Vall d'Hebron) ; Rodríguez Acevedo, Breogán (Hospital Universitari Vall d'Hebron) ; Zabalza, Ana (Hospital Universitari Vall d'Hebron) ; Galan, Ingrid (Hospital Universitari Vall d'Hebron) ; Nos, Carlos (Hospital Universitari Vall d'Hebron) ; Salerno, Annalaura (Hospital Universitari Vall d'Hebron) ; Auger, Cristina (Hospital Universitari Vall d'Hebron) ; Pareto, Deborah (Hospital Universitari Vall d'Hebron) ; Comabella, Manuel (Hospital Universitari Vall d'Hebron) ; Río, Jordi (Hospital Universitari Vall d'Hebron) ; Sastre-Garriga, Jaume (Hospital Universitari Vall d'Hebron) ; Rovira, Alex (Hospital Universitari Vall d'Hebron) ; Tintoré, Mar (Hospital Universitari Vall d'Hebron) ; Montalban, Xavier (Hospital Universitari Vall d'Hebron) ; Universitat Autònoma de Barcelona
This cohort study investigates the long-term outcomes of patients who develop progression independent of relapse activity after a first demyelinating event in multiple sclerosis. What are the long-term outcomes of patients developing progression independent of relapse activity (PIRA) after a first demyelinating event in multiple sclerosis? In this longitudinal cohort study including 1128 patients with a first demyelinating event in multiple sclerosis, presenting with PIRA was associated with significantly shorter times to developing severe disability compared with not presenting with PIRA. [...]
2022 - 10.1001/jamaneurol.2022.4655
JAMA Neurology, Vol. 80 (december 2022) , p. 151-160  
9.
145 p, 40.7 MB Susceptibility, severity and immunological factors against SARSCoV- 2 infection in patients with Multiple Sclerosis / Zabalza de Torres, Ana ; Tintoré Subirana, Mar, dir. ; Arrambide, Georgina, dir. ; Roquer González, Jaume, dir.
Considerant que els pacients amb esclerosi múltiple (EM) presenten un major risc de morbimortalitat secundari a infeccions i que aquest risc es troba incrementat en aquells amb tractament immunosupressors, quan la pandèmia de COVID-19 va començar va quedar palès que era crucial estudiar quins pacients amb EM presentaven major risc de COVID-19 i com influïa el tractament en aquest risc. [...]
Considerando que los pacientes con esclerosis múltiple (EM) presenta un mayor riesgo de morbimortalidad secundaria a infecciones y que este riesgo se encuentra incrementado en aquellos con tratamientos inmunosupresores, cuando la pandemia de COVID-19 inició se puso de manifiesto que era crucial estudiar cuales eran los pacientes con EM que presentaban una mayor riesgo de COVID-10 y como influía el tratamiento en este riesgo. [...]
Given that MS patients are at higher risk of morbimortality due to infection and that this risk is increased in those under immunosuppressant treatments, when the COVID-19 pandemic started it was crucial to study which MS patients where at higher risk of COVID-19 and how DMT influenced in this risk. [...]

2022  
10.
11 p, 1.2 MB Women's Health in Multiple Sclerosis : A Scoping Review / Ross, Lindsay (Mellen Center for Multiple Sclerosis Treatment and Research. Department of Neurology) ; Ng, Huah Shin (University of British Columbia. Department of Medicine) ; O'Mahony, Julia (University of Manitoba. Department of Internal Medicine) ; Amato, Maria Pia (University of Florence) ; Cohen, Jeffrey A. (Mellen Center for Multiple Sclerosis Treatment and Research. Department of Neurology) ; Harnegie, Mary Pat (Cleveland Clinic) ; Hellwig, Kerstin (Ruhr University. Department of Neurology) ; Tintoré, Mar (Hospital Universitari Vall d'Hebron) ; Vukusic, Sandra (Université Claude Bernard Lyon 1) ; Marrie, Ruth Ann (University of Manitoba. Department of Community Health Sciences) ; Universitat Autònoma de Barcelona
Women with multiple sclerosis (MS) may face challenges related to managing reproduction, pregnancy, and menopause while simultaneously managing their disease. The purpose of this scoping review was to map the literature broadly related to topics relevant to women's health in MS to inform the clinical and research communities about the existing types and sources of evidence and knowledge gaps. [...]
2022 - 10.3389/fneur.2021.812147
Frontiers in neurology, Vol. 12 (january 2022)  

Depósito Digital de Documentos de la UAB : Encontrados 27 registros   1 - 10siguientefinal  ir al registro:
¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.